Bridging the Gap: The Crucial Role of Private Healthcare in Achieving Universal Health Coverage

By Staff Writer

September 1, 2023

The World Bank Group (2017) estimates that at least half of the world’s population lacks access to basic healthcare. Moreover, nearly 100 million people are plunged into poverty annually due to healthcare expenses. These gaps in health provision are notably severe in low-income countries (LICs), where the majority of those facing impoverishing health expenses reside.

Universal Health Coverage (UHC) – defined as the global aim to ensure everyone receives the health services they need without suffering financial hardship – has been proposed as a solution to this pressing issue. The World Health Organisation (WHO) conceptualizes UHC as a ‘cube’ comprising three key dimensions: population coverage, service coverage, and financial risk protection.


Source: Authors’ own elaboration, adapted from Kutsin (2013) and the WHO UHC cube (World Health Organisation, 2010; Kutzin, 2013).

However, the role of private healthcare in achieving UHC remains a subject of ongoing debate. While the public and private health sectors interact and shape each other’s performance, the unclear boundaries between the two make it difficult to define a UHC role for the private sector.

Private-for-profit (PFP) providers, motivated by commercial interests, and private not-for-profits (PNFPs), usually driven by philanthropic motives, are the two main types of private healthcare providers. The central role of profit in PFPs has ignited debate on their ability to adequately serve the poor and whether they can be contracted by governments to advance UHC goals.

The informal sector in LICs, which includes traditional birth attendants and healers, unlicensed drug shops, and market stalls, provides a substantial proportion of healthcare, particularly for the poor. However, the quality of care in both the public and private sectors in LICs often falls short, particularly at the lower end of the market.

A recent study extends the debate on the role of private healthcare in LICs by systematically reviewing recently published literature. They found that while formal private providers typically operate in already well-served urban settings, informal and not-for-profit ones cater to patients in underserved rural areas and generally at the lower end of the health market.

However, improving the quality and financing of informal providers may be key to expanding UHC in LICs. Given their ubiquitous nature and diversity of contributions, mechanisms for (self) accreditation will need to be strengthened to guarantee a minimum level of service quality from these actors.

Quality and effectiveness should be considered core principles of universal coverage and represent an additional dimension of the UHC cube in its own right.

Reference url

Recent Posts

lenacapavir HIV PrEP access
    

Global Health Partnerships Unite to Expand Access to Lenacapavir for HIV Prevention

💉 How can we ensure equitable access to HIV prevention methods like lenacapavir?

A recent initiative from the Global Fund, supported by key global health organizations, aims to provide affordable access to this new HIV pre-exposure prophylaxis medication.

With a goal to reach 2 million individuals over three years, this coordinated effort seeks to drastically cut HIV infections and align with our commitment to ending AIDS by 2030.

Explore the details of this impactful collaboration and how it could transform HIV prevention.

#SyenzaNews #globalhealth #HealthcareInnovation #MarketAccess

antimicrobial resistance africa
     

Africa’s Health Crisis: Antimicrobial Resistance and Mpox Outbreak

🌍 Are we prepared to tackle the hidden pandemic of antimicrobial resistance (AMR) in Africa?

With AMR rapidly becoming a dominant health crisis, it’s critical to understand its impact on our healthcare systems and most vulnerable populations.

The Africa CDC highlights the urgent need for substantial investment and coordinated responses to combat this escalating threat, alongside the ongoing Mpox outbreak.

Discover the pressing challenges and potential solutions in our latest article.

#SyenzaNews #GlobalHealth #HealthcareInnovation #AntimicrobialResistance #PublicHealth

BioSapien cancer drug delivery
    

BioSapien Innovative Cancer Drug Delivery Solutions

🌟 How is innovation in drug delivery shaping the future of cancer treatment? 🌟

Discover how UAE-based BioSapien is transforming the healthcare landscape with the MediChip™ platform, securing $5.5 million in pre-Series A funding to enhance cancer care.

This innovative solution promises to minimise side effects and improve treatment outcomes for patients, fully embracing the potential of biotechnology in the fight against cancer.

Read more about BioSapien’s journey and its impact on global health!

#SyenzaNews #biotechnology #oncology #innovation #HealthTech

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2024 Syenza™. All rights reserved.